academic article

• Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia..  Leukemia.  32:2126-2137. 2018
• Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children's oncology group (COG) clinical trials..  Leukemia & lymphoma.  59:1624-1633. 2018
• Dysregulated transcriptional networks in KMT2A- and MLLT10-rearranged T-ALL..  Biomarker research.  6:-. 2018
• Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. 2016
• Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia..  Nature communications.  7:-. 2016
• MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: A children's oncology group study..  Leukemia.  :-. 2016
• Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434. 2015
• Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232..  Blood.  :-. 2015
• A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults. 2015
• Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia..  Nature communications.  6:-. 2015
• Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. 2014
• Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project..  Blood.  121:485-488. 2013
• ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology.  30:751-757. 2012
• Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study..  Blood.  119:1872-1881. 2012
• Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia..  Cancer cell.  22:153-166. 2012
• Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia..  Blood.  120:4197-4204. 2012
• Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study..  Blood.  119:3512-3522. 2012
• The genetic basis of early T-cell precursor acute lymphoblastic leukaemia..  Nature.  481:157-163. 2012
• Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia..  Nature genetics.  43:237-241. 2011
• Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group..  Blood.  118:3080-3087. 2011
• Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia..  Blood.  115:1394-1405. 2010
• Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome..  Blood.  116:4874-4884. 2010
• Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia..  Blood.  115:5312-5321. 2010
• Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia..  The New England journal of medicine.  360:470-480. 2009
• Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia..  JAMA.  301:393-403. 2009
• Germline genomic variants associated with childhood acute lymphoblastic leukemia..  Nature genetics.  41:1001-1005. 2009
• JAK mutations in high-risk childhood acute lymphoblastic leukemia..  Proceedings of the National Academy of Sciences of the United States of America.  106:9414-9418. 2009
• Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group..  Blood.  110:1429-1438. 2007
• Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296. 2006
• Resolution of ambiguous low-level positive quantitative polymerase chain reaction results in TEL-AML1 positive ALL using a post-PCR fluorescent oligoligation method..  British journal of haematology.  135:358-361. 2006